Business ❯ Corporate Strategy ❯ Mergers and Acquisitions ❯ Market Competition
Management pointed to stronger non‑Covid drug sales and the $10 billion Metsera deal as steps to offset weakening revenue from the vaccine plus antiviral Paxlovid.
